Intelligent Retinal Implant System

DEVICE2 trials

Sponsors

Science Corporation

Conditions

ChoroideremiaCone Rod DystrophyRetinitis Pigmentosa

Unknown Phase

Restoring Vision With the Intelligent Retinal Implant System (IRIS V1)in Patients With Retinal Dystrophy

CompletedNCT01864486

Science CorporationChoroideremia, Cone Rod Dystrophy, Retinitis Pigmentosa

Start: 2013-04-30End: 2017-10-13Target: 20Updated: 2017-10-17

Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal Dystrophy

CompletedNCT02670980

Science CorporationChoroideremia, Cone Rod Dystrophy, Retinitis Pigmentosa

Start: 2016-01-31End: 2019-05-31Updated: 2019-05-29

Related Papers

Update on Gene Therapy Clinical Trials for Choroideremia and Potential Experimental Therapies.

2021-01-1210 citations